Optimisation of oral anticoagulants for patients with atrial fibrillation within 12â¯months after percutaneous coronary intervention: A meta-analysis and systematic review.
Int J Cardiol Heart Vasc
; 36: 100850, 2021 Oct.
Article
em En
| MEDLINE
| ID: mdl-34401468
95% CI, 95% confidence intervals; AF, Atrial fibrillation; Antithrombotic therapy; Atrial fibrillation; DAT, Oral anticoagulants plus single antiplatelet therapy; IIa, Factor IIa; ISTH, International Society on Thrombosis and Hemostasis; MI, Myocardial infarction; NOACs, Novel oral anticoagulants; OACs, Oral anticoagulants; Oral anticoagulant; PCI, Percutaneous coronary intervention; Percutaneous coronary intervention; RR, Risk ratios; SD, Standard deviation; SUCRA, Surface under the cumulative ranking curve; TAT, Vitamin K antagonist plus a P2Y12 inhibitor and aspirin; TIMI, Thrombolysis In Myocardial Infarction; VKA, Vitamin K antagonist; Xa, Factor Xa
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
/
Systematic_reviews
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article